Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.

Goebell PJ, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, Lennartz C, Koska M, Potthoff K, Kaiser-Osterhues A, Grüllich C, Staehler M, Jänicke M, Marschner D, CARAT Registry Group

Open source

DOI
10.1002/ijc.70211
Published
2026 Mar 15
Container
International journal of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.70211,
  title = {Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.},
  author = {Goebell PJ and Bögemann M and Nusch A and Grünwald V and Müller L and von der Heyde E and Martens UM and Lennartz C and Koska M and Potthoff K and Kaiser-Osterhues A and Grüllich C and Staehler M and Jänicke M and Marschner D and CARAT Registry Group},
  year = {2026},
  journal = {International journal of cancer},
  doi = {10.1002/ijc.70211},
  url = {https://doi.org/10.1002/ijc.70211}
}

RIS

TY  - JOUR
TI  - Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.
AU  - Goebell PJ
AU  - Bögemann M
AU  - Nusch A
AU  - Grünwald V
AU  - Müller L
AU  - von der Heyde E
AU  - Martens UM
AU  - Lennartz C
AU  - Koska M
AU  - Potthoff K
AU  - Kaiser-Osterhues A
AU  - Grüllich C
AU  - Staehler M
AU  - Jänicke M
AU  - Marschner D
AU  - CARAT Registry Group
PY  - 2026
JO  - International journal of cancer
DO  - 10.1002/ijc.70211
UR  - https://doi.org/10.1002/ijc.70211
ER  - 

APA

PJ, G., M, B., A, N., V, G., L, M., E, V. D. H., UM, M., C, L., M, K., K, P., A, K., C, G., M, S., M, J., D, M., & Group, C. R. (2026). Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma-Real-world data from the German research platform CARAT.. International journal of cancer. https://doi.org/10.1002/ijc.70211

Source records